Hydroxylation of lansoprazole in poor metabolizers of CYP2C19
- PMID: 16487234
- PMCID: PMC1885018
- DOI: 10.1111/j.1365-2125.2005.02551.x
Hydroxylation of lansoprazole in poor metabolizers of CYP2C19
Comment on
-
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.Br J Clin Pharmacol. 2005 Mar;59(3):302-9. doi: 10.1111/j.1365-2125.2004.02329.x. Br J Clin Pharmacol. 2005. PMID: 15752376 Free PMC article. Clinical Trial.
References
-
- Furuta T, Ohashi K, Kobayashi K, Iida I, Yoshida H, Shirai N, Takashima M, Kosuge K, Hanai H, Chiba K, Ishizaki T, Kaneko E. Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. Clin Pharmacol Ther. 1999;66:265–74. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
